Načítá se...
Translational medicine in neuromuscular disorders: from academia to industry
Although around half of US Food and Drug Administration (FDA)-approved drugs originate from discoveries made in academic research laboratories, the US National Institutes of Health (NIH) estimates that nearly 90% of therapies developed in preclinical stages never reach clinical trials. From those in...
Uloženo v:
| Vydáno v: | Dis Model Mech |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Company of Biologists Ltd
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6906629/ https://ncbi.nlm.nih.gov/pubmed/31658990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1242/dmm.041434 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|